Alvin Wong
Chief Tech/Sci/R&D Officer presso PUMA BIOTECHNOLOGY, INC.
Patrimonio netto: 748 577 $ in data 31/03/2024
Profilo
Alvin F.
Wong is currently the Chief Scientific Officer at Puma Biotechnology, Inc. He previously worked as the Senior Director-Clinical Development at Proteolix, Inc. from 2007 to 2013.
Prior to that, he served as a Clinical Professor at UCSF School of Pharmacy from 1976 to 1996.
Dr. Wong holds a graduate degree from The University of California, San Francisco.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0.29% | 12/02/2024 | 141 241 ( 0.29% ) | 748 577 $ | 31/03/2024 |
Posizioni attive di Alvin Wong
| Società | Posizione | Inizio |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01/08/2017 |
Precedenti posizioni note di Alvin Wong
| Società | Posizione | Fine |
|---|---|---|
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Corporate Officer/Principal | 01/01/2013 |
| UCSF School of Pharmacy | Corporate Officer/Principal | 01/01/1996 |
Formazione di Alvin Wong
| The University of California, San Francisco | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
- Borsa valori
- Insiders
- Alvin Wong
